Top

Supportive Care in Cancer

Published in:

Open Access 01-12-2021 | Insomnia | Original Article

Assessment of sleep problems with the Insomnia Severity Index (ISI) and the sleep item of the Patient Health Questionnaire (PHQ-9) in cancer patients

Authors: Thomas Schulte, Dirk Hofmeister, Anja Mehnert-Theuerkauf, Tim Hartung, Andreas Hinz

Published in: Supportive Care in Cancer | Issue 12/2021

Abstract

Objective

The objectives of this study were to examine sleep problems in cancer patients, to test the psychometric properties of the Insomnia Sleep Index (ISI) in comparison with the sleep item of the Patient Health Questionnaire-9 (PHQ-9), and to analyze disrupting factors which might cause the sleep problems.

Methods

A sample of 1026 mixed-site cancer patients in treatment at a German oncological rehabilitation clinic was examined.

Results

The reliability of the ISI was very good (Cronbach’s alpha = 0.92), and the results of the confirmatory factor analysis were acceptable. Females reported worse sleep quality (ISI mean: 13.7 ± 6.6) than males (10.7 ± 6.4). Sleep problems as measured with the PHQ-9 sleep item were markedly higher than those in the general population (effect size d = 1.15).

Patients reported that, of the factors that disrupted their sleep, psychological factors (brooding, worries) were more relevant than symptom factors (pain, nocturnal urination, or restless legs).

Conclusions

The ISI is effective in detecting sleep problems in cancer patients. Normative studies with the ISI would be helpful for assessing ISI mean scores. Sex differences should be taken into account when groups of patients are compared. The sleep item of the PHQ-9 can be used in epidemiological studies.

Otte JL, Carpenter JS, Manchanda S, Rand KL, Skaar TC, Weaver M, Chernyak Y, Zhong X, Igega C, Landis C (2015) Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained? Cancer Med 4:183–200PubMedCrossRef

Lin C-Y, Cheng ASK, Nejati B, Imani V, Ulander M, Browall M, Griffiths MD, Broström A, Pakpour AH (2020) A thorough psychometric comparison between Athens Insomnia Scale and Insomnia Severity Index among patients with advanced cancer. J Sleep Res 29:e12891PubMedCrossRef

Schieber K, Niecke A, Geiser F, Erim Y, Bergelt C, Büttner-Teleaga A, Maatouk I, Stein B, Teufel M, Wickert M, Wuensch A, Weis J (2019) The course of cancer-related insomnia: don’t expect it to disappear after cancer treatment. Sleep Med 58:107–113PubMedCrossRef

Liu L, Fiorentino L, Rissling M, Natarajan L, Parker BA, Dimsdale JE, Mills PJ, Sadler GR, Ancoli-Israel S (2013) Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med 11:189–206PubMedCrossRef

Chen M-L, Yu C-T, Yang C-H (2008) Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer 62:391–400PubMedCrossRef

Hofmeister D, Schulte T, Hinz A (2020) Sleep problems in cancer patients: a comparison between the Jenkins Sleep Scale and the single-item sleep scale of the EORTC QLQ-C30. Sleep Med 71:59–65PubMedCrossRef

Weinger MB, Ancoli-Israel S (2002) Sleep deprivation and clinical performance. JAMA 287:955–957PubMedCrossRef

Henneghan AM, Carter P, Stuifbergan A, Parmelee B, Kesler S (2018) Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy. Psychooncology 27:1937–1943PubMedCrossRef

Phipps AI, Bhatti P, Neuhouser ML, Chen C, Crane TE, Kroenke CH, Ochs-Balcom H, Rissling M, Snively BM, Stefanick ML, Treggiari MM, Watson NF (2016) Pre-diagnostic sleep duration and sleep quality in relation to subsequent cancer survival. J Clin Sleep Med 12:495–503PubMedPubMedCentralCrossRef

10.

Gottfried T, Kamer I, Salant I, Urban D, Lawrence YR, Onn A, Bar J (2020) Self-reported sleep quality as prognostic for survival in lung cancer patients. Cancer Manage Res 12:313–321CrossRef

11.

Zhou ES, Partridge AH, Syrjala KL, Michaud AL, Recklitis CJ (2017) Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv 11:74–79PubMedCrossRef

12.

Kwak A, Jacobs J, Haggett D, Jimenez R, Peppercorn J (2020) Evaluation and management of insomnia in women with breast cancer. Breast Cancer Res Treat 181:269–277PubMedCrossRef

13.

Chen D, Yin Z, Fang B (2018) Measurements and status of sleep quality in patients with cancers. Support Care Cancer 26:405–414PubMedCrossRef

14.

Morin CM, Belleville G, Bélanger L, Ivers H (2011) The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34:601–608PubMedPubMedCentralCrossRef

15.

Yusufov M, Zhou ES, Recklitis CJ (2019) Psychometric properties of the Insomnia Severity Index in cancer survivors. Psychooncology 28:540–546PubMedCrossRef

16.

Savard M-H, Savard J, Simard S, Ivers H (2005) Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology 14:429–441PubMedCrossRef

17.

Castronovo V, Galbiati A, Marelli S, Brombin C, Cugnata F, Giarolli L, Anelli MM, Rinaldi F, Ferini-Strambi L (2016) Validation study of the Italian version of the Insomnia Severity Index (ISI). Neurol Sci 37:1517–1524PubMedCrossRef

18.

Chen P-Y, Yang C-M, Morin CM (2015) Validating the cross-cultural factor structure and invariance property of the Insomnia Severity Index: evidence based on ordinal EFA and CFA. Sleep Med 16:598–603PubMedCrossRef

19.

Tibubos AN, Zenger M, Schmalbach B, Beutel ME, Brähler E (2020) Measurement invariance, validation and normative data of the Jenkins Sleep Scale-4 (JSS-4) in the German general population across the life span. J Psychosom Res 130:109933PubMedCrossRef

20.

Hinz A, Glaesmer H, Brähler E, Löffler M, Engel C, Enzenbach C, Hegerl U, Sander C (2017) Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med 30:57–63PubMedCrossRef

21.

Santoso AMM, Jansen F, Lissenberg-Witte BI, Baatenburg de Jong RJ, Langendijk JA, Leemans CR, Smit JH, Takes RP, Terhaard CHJ, van Straten A, Verdonck-de Leeuw IM (2021) Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors. Support Care Cancer 29:1035–1045PubMedCrossRef

22.

Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9 - validity of a brief depression severity measure. J Gen Intern Med 16:606–613PubMedPubMedCentralCrossRef

23.

Romppel M, Braehler E, Roth M, Glaesmer H (2013) What is the General Health Questionnaire-12 assessing? Dimensionality and psychometric properties of the General Health Questionnaire-12 in a large scale German population sample. Compr Psychiatry 54:406–413PubMedCrossRef

24.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Dehaes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European-Organization-For-Research-And-Treatment-Of-Cancer QLQ-C30 - a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef

25.

Mercadante S, Adile C, Ferrera P, Masedu F, Valenti M, Aielli F (2017) Sleep disturbances in advanced cancer patients admitted to a supportive/palliative care unit. Support Care Cancer 25:1301–1306PubMedCrossRef

26.

Bastien CH, Vallieres A, Morin CM (2001) Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2:297–307PubMedCrossRef

27.

Gerber LH, Stout N, McGarvey C, Soballe P, Shieh CY, Diao GQ, Springer BA, Pfalzer LA (2011) Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Supp Care Cancer 19:1581–1591CrossRef

28.

Kocalevent RD, Hinz A, Brahler E (2013) Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry 35:551–555PubMedCrossRef

29.

Löwe B, Kroenke K, Grafe K (2005) Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 58:163–171PubMedCrossRef

30.

Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brähler E (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86–95PubMedCrossRef

31.

Hinz A, Klein AM, Brähler E, Glaesmer H, Luck T, Riedel-Heller SG, Wirkner K, Hilbert A (2017) Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord 210:338–344PubMedCrossRef

32.

Kazlauskas E, Gegieckaite G, Eimontas J, Zelviene P, Maercker A (2018) A brief measure of the International Classification of Diseases-11 adjustment disorder: investigation of psychometric properties in an adult help-seeking sample. Psychopathology 51:10–15PubMedCrossRef

33.

Zelviene P, Kazlauskas E, Eimontas J, Maercker A (2017) Adjustment disorder: empirical study of a new diagnostic concept for ICD-11 in the general population in Lithuania. Eur Psychiatry 40:20–25PubMedCrossRef

34.

El Fassi M, Bocquet V, Majery N, Lair ML, Couffignal S, Mairiaux P (2013) Work ability assessment in a worker population: comparison and determinants of Work Ability Index and Work Ability score. BMC Public Health 13:305PubMedPubMedCentralCrossRef

35.

Cella D, Davis K, Breitbart W, Curt G (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391PubMedCrossRef

36.

Kuhnt S, Friedrich M, Schulte T, Cella D, Hinz A (2019) Screening properties of the diagnostic criteria for cancer-related fatigue. Oncol Res Treat 42:440–445PubMedCrossRef

37.

Cohen J (1988) Statistical power analysis for the behavioral sciences. Hillsdale, NJ, Erlbaum, 1988, vol 2.

38.

Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equat Modeling 6:1–55CrossRef

39.

Hinz A, Mehnert A, Kocalevent R-D, Brähler E, Forkmann T, Singer S, Schulte T (2016) Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatry 16:22PubMedPubMedCentralCrossRef

40.

Cho YW, Song ML, Morin CM (2014) Validation of a Korean version of the insomnia severity index. J Clin Neurol 10:210–215PubMedPubMedCentralCrossRef

41.

Gerber M, Lang C, Lemola S, Colledge F, Kalak N, Holsboer-Trachsler E, Pühse U, Brand S (2016) Validation of the German version of the insomnia severity index in adolescents, young adults and adult workers: results from three cross-sectional studies. BMC Psychiatry 16:174PubMedPubMedCentralCrossRef

42.

Dragioti E, Levin L-Å, Bernfort L, Larsson B, Gerdle B (2017) Insomnia severity and its relationship with demographics, pain features, anxiety, and depression in older adults with and without pain: cross-sectional population-based results from the PainS65+ cohort. Ann Gen Psychiatry 16:15PubMedPubMedCentralCrossRef

43.

Dieck A, Morin CM, Backhaus J (2018) A German version of the Insomnia Severity Index. Somnologie 22:27–35CrossRef

44.

Spielman AJ, Glovinsky P (1991) Case studies in insomnia. In: Hauri PJ (ed) The varied nature of insomnia. Plenum Press, New York, pp 1–15

45.

Savard J, Savard M-H (2013) Insomnia and cancer. Sleep Med Clin 8:373–387CrossRef

46.

Howell D, Oliver TK, Keller-Olaman S, Davidson J, Garland S, Samuels C, Savard J, Harris C, Aubin M, Olson K, Sussman J, Macfarlane J, Taylor C (2013) A Pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer 21:2695–2706PubMedCrossRef

47.

Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28PubMedCrossRef

48.

Kreutz C, Müller J, Schmidt ME, Steindorf K (2021) Comparison of subjectively and objectively assessed sleep problems in breast cancer patients starting neoadjuvant chemotherapy. Support Care Cancer 29:1015–1023PubMedCrossRef

49.

Jakobsen G, Engstrøm M, Thronæs M, Løhre ET, Kaasa S, Fayers P, Hjermstad MJ, Klepstad P (2021) Sleep quality in hospitalized patients with advanced cancer: an observational study using self-reports of sleep and actigraphy. Support Care Cancer 28:2015–2023CrossRef

50.

Hinz A, Weis J, Faller H, Brähler E, Härter M, Keller M, Schulz H, Wegscheider K, Koch U, Geue K, Götze H, Mehnert A (2018) Quality of life in cancer patients-a comparison of inpatient, outpatient, and rehabilitation settings. Support Care Cancer 26:3533–3541PubMedCrossRef

Title: Assessment of sleep problems with the Insomnia Severity Index (ISI) and the sleep item of the Patient Health Questionnaire (PHQ-9) in cancer patients
Authors: Thomas Schulte
Dirk Hofmeister
Anja Mehnert-Theuerkauf
Tim Hartung
Andreas Hinz
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keyword: Insomnia
Published in: Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06282-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2021

Taste alterations and oral discomfort in patients receiving chemotherapy

Addressing sexual concerns of female breast cancer survivors and partners: a qualitative study of survivors, partners, and oncology providers about Internet intervention preferences

The effectiveness of an oral health education and prevention program on the incidence and severity of oral mucositis in pediatric cancer patients: a non-randomized controlled study

The use of guarana (Paullinia cupana) as a dietary supplement for fatigue in cancer patients: a systematic review with a meta-analysis

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction

Longitudinal changes in spiritual well-being and associations with emotional distress, pain, and optimism–pessimism: a prospective observational study of terminal cancer patients admitted to a palliative care unit

Keynote webinar | Spotlight on antibody–drug conjugates in cancer